Whats New

Arrotex’ major new partnership

Arrotex bolsters respiratory portfolio with new Boehringer Ingelheim partnership Media Release February 6, 2020 Arrotex Pharmaceuticals Pty Ltd is today announcing a strategic partnership with Boehringer Ingelheim Pty Ltd for the exclusive Australian reseller rights to respiratory products* Spiriva® (tiotropium 18 micrograms powder for inhalation) and Spiriva® HandiHaler®. Following the …

Read More »